uptake in cells grown at 1% oxygen were not increased by addition of hCG (2,500 IU/l). We infer that placental NIS mRNA and protein expression are regulated by oxygen, rising with vascularization of the placenta in the late first trimester, a time when fetal iodide requirements are increasing.
human chorionic gonadotropin; placenta; hypoxia; thyroid hormone NORMAL FETAL DEVELOPMENT IS DEPENDENT on an adequate supply of thyroid hormone (TH) throughout gestation. Before the human fetal thyroid begins to secrete TH at about 16 wk gestation, the fetus must derive its TH from the maternal circulation. Subsequently, although materno-fetal TH transport appears, to some degree, to continue throughout pregnancy (10, 61) , the fetus synthesizes TH from maternally derived iodine. This can be drawn from placental deiodination of maternal TH and by placental transport of maternal iodide (21) . Iodine deficiency is the greatest single cause of preventable brain damage (9) . When compounded by the physiological increases in iodine requirements of pregnancy, even mild iodine deficiency can result in impaired fetal production of TH (45, 51, 65) .
Iodide transport into the thyroid follicle and across the placenta share many features. Within the thyroid gland, iodide is actively taken up by thyrocytes via the basal cell membrane sodium iodide symporter (NIS) (14, 39, 57) . It is then discharged into the thyroid follicle through the apical cell membrane anion transporter pendrin. Pendrin is an anion exchanger (37, 50, 53, 55) and is activated by high concentrations of intracellular iodide (63) . The pituitary glycoprotein TSH upregulates NIS expression and iodide uptake (5, 29) , whereas iodide has the opposite effect (15) . In placenta, materno-fetal transfer of iodide involves iodide uptake through the apical trophoblast cell membrane and efflux through the basal cell membrane. NIS is expressed in the apical trophoblast cell membrane, which faces the maternal circulation. Conversely, Pendrin is expressed in the basal trophoblast cell membrane, and the two iodide transporters mediate iodide transfer in placenta (7, 37, 40) . Trophoblasts synthesize and secrete large amounts of human chorionic gonadotropin (hCG), which has significant homologies with TSH. hCG has autocrine effects on trophoblast cells via the hCG-leutinizing hormone receptor, resulting in the upregulation of NIS expression. Iodide downregulates both NIS and hCG expression in trophoblast (4, 33) .
It is becoming increasingly apparent that expression of many placental genes and the development of the placenta itself are linked to changing oxygen (O 2 ) concentrations (44) . Early in pregnancy the placenta is relatively avascular, and O 2 concentrations in the placental villi (the exchange units of the placenta) are very low, ϳ20 mmHg (1-3%). By 16 wk gestation the villi are vascularized, and O 2 tensions rise to about ϳ60 mmHg (8%), which in normal pregnancies is maintained until birth (19, 23, 49) . These physiologically relevant low O 2 concentrations are much less than the 21% O 2 concentrations of room air, in which many placental experiments have usually been conducted. Numerous studies have reported the intrinsic role of hypoxia (Ͻ5% O 2 ) in regulating placental implantation and function (19, 44, 46) , suggesting that several different molecular mechanisms may be involved. However, only a small number of studies have focused on low O 2 concentrations and placental transport function. Nelson et al. (41) have demonstrated downregulation in the expression and function of system A amino acid transporters in isolated term human trophoblast cells cultured under hypoxic conditions. Another study has observed the upregulation of glucose transporters by hypoxia in the BeWo choriocarcinoma cell line (6) .
In this study, we have investigated the expression of NIS and interactions with hCG under O 2 levels similar to those of the developing placenta (1, 8 , and 21% O 2 of room air) and evaluated the roles of O 2 in the regulation of NIS gene expression and iodide uptake in the established BeWo human choriocarcinoma cell line, previously used by us as a model of placental iodine transport (33, 37) . Real-time quantitative PCR. Total cellular RNA was isolated from cells using the RNeasy Mini Kit (Qiagen). RNA concentrations and quality were determined in a NanoDrop-1000 Spectrophotometer (NanoDrop Technologies, Wilmington, DE). Table 1 . ␤2-Microglobulin was used as an internal control gene. The real-time PCR method was validated by using serially diluted cDNA in a standard curve. To quantify the gene expression profile in each sample, the efficiency of each standard curve was determined by its slope and comparative threshold according to the manufacturer's instructions. For each sample, the amount of targeted mRNA (arbitrary units) was normalized to the housekeeping gene ␤2-microglobulin.
MATERIALS AND METHODS

Cell
Membrane protein preparation and Western blots. Membrane proteins were extracted by ProteinExtract Native Membrane Protein Extraction Kit (Merck), following the company protocol. Briefly, the monolayer of BeWo cells was washed twice with washing buffer. Extraction buffer I with protease inhibitors was added to the cells with gentle agitation for 10 min at 4°C, and the supernatant was discarded. The cell layers were then covered with extraction buffer II plus protease inhibitors and gently agitated for 30 min at 4°C. The supernatant containing the membrane fraction was placed into a sample tube, and membrane proteins were concentrated by an Amicon Ultra Centrifugal Filter (Millipore). Protein concentration was measured by a BCA protein assay kit (Pierce, Rockford, IL).
For electrophoresis, 30 g of membrane samples was prepared by addition of NuPAGE SDS sample buffer with reducing agent (NuPAGE, Novex; Invitrogen) and incubated at 70°C for 10 min. The samples were loaded in NuPAGE 4 -12% Bis-tris Gel (Invitrogen) and transferred to a 0.45-m nitrocellulose membrane (Bio-Rad Laboratories). The membrane was blocked with 5% skim milk in Tris-buffered saline [20 mM Tris-Cl, pH 7.4, 137 mM NaCl, 0.05% Tween-20 (TBST)] for 45 min at room temperature. The blots were then probed with monoclonal anti-NIS antibody diluted 1:400 (Chemicon) in blocking buffer overnight at 4°C or monoclonal anti-␤-actin antibody diluted 1:2,000 (Sigma) for 1 h at room temperature. After washing three times with TBST, the membrane was probed with horseradish peroxidase-conjugated secondary antibody 1:2,000 (ImmunoPure peroxidase-conjugated goat anti-mouse IgG; Pierce) in blocking buffer and washed as before. The signals were visualized with Super Signal West Femto Maximum Sensitivity Substrate (Pierce) and detected by FujiFilm Luminescent Image Analyzer LAS-4000 (FujiFilm, Tokyo, Japan). The amount of chemiluminescence of NIS and ␤-actin bands was measured using FujiFilm Multi Gauge Version 3.0 software. Data are presented as ratio of density of NIS to ␤-actin.
Radioiodide uptake. Radiolabeled iodide ( 125 I) as NaI, carrierfree in NaOH, was obtained from PerkinElmer (Glen Waverleyl, New South Wales, Australia).
125 I uptake assay was performed as described previously (37) . Briefly, BeWo cells were incubated in 2 ml of serum-free DMEM with 125 I (1 kBq/ml) for 1 h at 37°C and then solubilized in 1 ml of 1 M NaOH and the wells rinsed with an additional 1 ml of NaOH. The level of 125 I uptake was quantified by measuring 125 I in 2 ml of solubilized cell extract in a ␥-counter. Immunoassay. hCG secreted into cell culture medium was measured by a sandwich immunoassay using direct chemiluminometric technology (Access Immunoassay System, Total ␤hCG Assay; Beckman Coulter). Two antibodies were used in the assay, goat polyclonal anti-␤hCG antibody and mouse monoclonal anti-␤hCG antibody. Each antibody reacts with a specific ␤hCG epitope and detects both free ␤-subunit hCG and ␤-subunit of intact hCG. The assay was performed according to the manufacturer's instructions.
Statistics. Statistical analysis was performed using GraphPad Prism Version 4.0 Software (GraphPad Sofware, San Diego, CA). Comparison between groups was done by one-way ANOVA with Bonferroni's post hoc test to analyze differences between the means of treatment groups and the control group. Results are expressed as means Ϯ SE, and P values of Ͻ0.05 were considered significant. All experiments were repeated at least twice on separate cell cultures and performed in triplicate for each treatment group. (Fig. 1A) and was mirrored by increased membrane NIS protein (Fig. 1B) and I 125 uptake (Fig. 1C) . Addition of DFO (a hypoxia mimetic) to BeWo cells incubated in 21% O 2 significantly reduced NIS mRNA expression in a time-dependent manner ( Fig. 2A) . These reductions were reflected in significant falls in membrane NIS protein and I 125 uptake after 24 and 48 h of DFO treatment (Fig. 2, B and C) . To exclude a direct effect of DFO on NIS functional iodide uptake, I
125 uptake was also examined in BeWo cells after 4-h incubation of DFO, which showed no difference in uptake compared with 21% O 2 (data not shown).
hCG mRNA also increased in parallel with NIS mRNA with increasing O 2 concentrations (Fig 1A) . The increased hCG mRNA was accompanied by increases in hCG protein secretion. The concentration of hCG in the culture medium was 95.27 Ϯ 2.18 IU/l in 1%, 412.23 Ϯ 66.02 IU/l in 8%, and 539.36 Ϯ 74.46 IU/l in 21% O 2 (Fig. 3A) . A time course study showed that the fold decrease of NIS mRNA was 4.25 Ϯ 0.72-(P Ͻ 0.001), 6.7 Ϯ 0.82-(P Ͻ 0.001), and 15.45 Ϯ 0.98-fold (P Ͻ 0.001) after 8, 24, and 48 h, respectively, in 1% O 2 compared with 21% O 2 , whereas expression of hCG mRNA was 1.8 Ϯ 0.42-(P Ͻ 0.05), 3.3 Ϯ 0.82-(P Ͻ 0.01), and 2.6 Ϯ 0.78-fold (P Ͻ 0.05), respectively (Fig. 4) . Expression of hCG mRNA and protein secretion were reduced significantly by DFO but only after 24 h of incubation ( Figs. 2A and 3B) .
To determine the hCG effect on NIS expression at changing O 2 concentrations, BeWo cells were treated with or without 25,000 IU/l of hCG for 4, 8, and 24 h in 1 or 8% O 2 . No difference in NIS expression was observed at 1% O 2 culture after hCG treatment compared with cultures without hCG treatment (Fig. 5A) . However, hCG increased NIS mRNA expression in BeWo cells incubated in 8% O 2 , with statistical significance (P Ͻ 0.05) at 24 h (Fig. 5A ). There was no measurable increase in I 125 uptake at either O 2 concentration after 48-h hCG treatment (Fig. 5B) .
DISCUSSION
BeWo cells, derived originally from a human choriocarcinoma, share many features with trophoblasts in primary culture. BeWo cells form a well-differentiated monolayer, undergo syncytialization, and secrete hCG (8, 35, 58) . They have been used widely in placental transport studies, e.g., glucose (1, 3, 6, 13, 25, 38) , amino acid (25, 26, 42) , iron (12, 18) , fatty acid (24, 60) , and drug and toxic studies (2, 22, 36, 47) . BeWo cells express NIS and pendrin and demonstrate significant uptake and efflux of iodide, with kinetic and inhibitory characteristics consistent with these transporters (37) . We have used these cells previously to model placental iodide handling and demonstrate iodide and hCG regulation on NIS (33, 37) .
In the present study, we examined the effects of incubating BeWo cells at O 2 levels observed in placental villi early in pregnancy (Յ6 wk gestation, 1% O 2 ) and from 16 wk gestation (8% O 2 ) (19, 23, 49) . BeWo cells cultured at 21% O 2 were used as controls. There was a significant increase in NIS mRNA and protein expression as oxygen levels rose from 1 to 8 to 21% O 2 (Fig. 1, A and B) . NIS functional studies conducted by I 125 uptake demonstrated increases in NIS expression (Fig. 1C) . DFO is an iron chelator and mimics hypoxia by inhibiting prolyl hydroxylases, which are essential for the proteosomal degradation of hypoxia-inducible factor-1␣ (HIF-1␣) during times of normoxia (Ͼ5% O 2 ), resulting in the nuclear accumulation of HIF-1␣ and its transcriptional effects (48) . DFO has been used extensively in many cell and tissue types and is recognized as the gold standard for creating a hypoxic environment under normoxic conditions (11, 48, 59) . In the present study, addition of DFO significantly reduced NIS mRNA and protein expression (Fig. 2, A and B) as well as I 125 uptake (Fig. 2C) . Our results indicate for the first time that increasing O 2 concentrations regulate NIS expression and iodide transport in BeWo cells, a model of placental trophoblasts. A number of studies have demonstrated that in normal pregnancy the O 2 tension in intervillous spaces of human placenta rises gradually from about 20 mmHg or 1-3% O 2 at 6 -12 wk gestation and peaks around 60 mmHg or 8% O 2 at about week 16. This correlates with morphological descriptions of early human placenta development that document direct connections between the spiral arteries and the intervillous space after only 9 wk of gestation (23) . Establishment of this well-oxygenated environment in the intercellular space is believed to play an important physiological role in stimulation of trophoblast differentiation (23, 46) . Human fetal thyroid begins to concentrate iodide and synthesize thyroid hormones from around 10 -12 wk of gestation and secretes thyroid hormones at about week 16 (10) . In our present study, increases in NIS expression and iodide uptake were observed as O 2 concentrations increased from 1 to 8%. We postulate that this in vitro model may represent the normal process of trophoblast differentiation and function during placental development. Thus the increasing maternal iodide requirements of the developing fetal thyroid are met by oxygen-induced increased trophoblast NIS expression. In abnormal pregnancies, such as those complicated by preeclampsia and intrauterine growth restriction, there is evidence of impaired placentation and vascularization. These pathologies can chronically reduce blood supply and may play a role in reducing placental exchange of key nutrients (such as iodide) to the fetus during pregnancy (56) . In vitro studies have indicated that placental transport of amino acids and glucose is regulated by a hypoxic environment (6, 41, 54, 64) . Furthermore, in human intrauterine growth restriction, the decrease of placental transporters of glucose and amino acids suggests that both placental metabolism and transport may be altered (34, 43, 54) . Clearly, further investigation to understand the role of hypoxia in regulating cellular transport functions is warranted.
hCG upregulates NIS expression in thyroid cells and placental cell lines (4, 5, 31, 33) . To examine whether the decrease of NIS expression in low O 2 levels could be contributed to by low hCG levels, we examined hCG mRNA expression and protein secretion in the same samples used for NIS. hCG mRNA and hCG secretion were reduced at 1% oxygen and increased significantly as oxygen concentration rose from 1 to 8 to 21% oxygen, as was seen with increased NIS expression (Figs. 1A and 3A) . Addition of DFO resulted in a decrease of both hCG mRNA expression ( Fig. 2A ) and protein secretion (Fig. 3B) , but only after 24 h treatment, whereas NIS decreased progressively in a time-dependent manner. These data indicate that hCG production is regulated by O 2 . The rapid and more significant effects of low (1%) O 2 concentration or DFO on NIS expression suggest that downregulation of NIS by low O 2 levels may not be mediated by low hCG production. To further investigate this, BeWo cells were incubated with 25,000 IU/l of hCG in 1 and 8% O 2 . In our present study, the mean of endogenous hCG concentration in the medium of 1% O 2 culture was 95.27 Ϯ 2.18 IU/l and in 8% oxygen was 413.23 Ϯ 66.02 IU/l. The concentration of added hCG was six times higher than the endogenous hCG in 8% oxygen culture. However, hCG did not increase low NIS expression or iodide uptake in cells cultured in 1% O 2 (Fig. 5) . We speculate that there may be two possible mechanisms of NIS regulation by oxygen. First, O 2 may have an effect on the downstream pathway of hCG action on NIS. Second, O 2 may have an independent effect on NIS. Hypoxia-inducible factors mediate transcriptional responses to localized hypoxia in normal tissues by altering cellular metabolism and stimulating angiogenesis (28) . Translocation of HIF-1␣ to the nucleus in response to hypoxia Fig. 4 . A time course study of the effects of oxygen on NIS and hCG mRNA expression in BeWo cells by quantitative real-time PCR. Data were represented as fold decrease in 1% oxygen compared with 21% oxygen and analyzed using 1-way ANOVA with Bonferroni's post hoc test. *P Ͻ 0.05; **P Ͻ 0.01; ***P Ͻ 0.001. regulates the expression of many genes, leading to decreased energy consumption and the release of proangiogenic factors subsequently changing cell function (32, 44) . Changes in tissue O 2 are also associated with generation of reactive O 2 species and alterations in intracellular reduction/oxidation (redox) status. This also plays an important role in DNA synthesis, gene expression, enzymatic activity, and other processes (20, 30) . During placental development, alteration of oxygen concentration in intervillous spaces is inevitably an alteration of redox status in trophoblast (17, 23, 62) . In thyroid, NIS transcription requires Pax8 DNA binding to its promoter and enhancer. This is regulated by hCG and redox status (16, 27, 52) . Although Pax8 is present in term human placenta, overexpression of Pax8 in JAR cells failed to increase NIS expression, suggesting a more complex mechanism of placental NIS regulation (16) . The molecular mechanism of O 2 involvement in the regulation of NIS expression and iodide transfer in placenta requires further investigation.
Maintaining normal placental iodide transfer is important for fetal thyroid hormone synthesis. The present study suggests that NIS expression and activity rise in parallel with increasing placental O 2 concentrations in early pregnancy, at a time when the developing fetal thyroid requires an increased supply of maternal iodide for thyroid hormone synthesis.
